“No End Point Detected”: A Unique Coagulation Profile Unmasking Dysfibrinogenemia

Dysfibrinogenemia is a rare qualitative fibrinogen disorder that can present with bleeding, thrombosis, or both. We report a case of a young woman with first-trimester pregnancy loss and severe hemorrhage, whose coagulation tests reported "no end point detected" on PT, PTT, and Clauss fibrinogen assays. This pattern should prompt consideration of profound hypofibrinogenemia or qualitative fibrinogen defects. Fibrinogen replacement normalized PT and PTT and yielded measurable fibrinogen levels, enabling definitive diagnosis. Discordant activity and antigen levels, along with a pathogenic <i>FGB</i> variant, confirmed dysfibrinogenemia. This case underscores the importance of considering fibrinogen disorders in uninterpretable coagulation profiles and initiating early replacement.

Authors

Institutions

Publication Details

Journal
Case Reports in Hematology
Published
2025-01-01
DOI
https://doi.org/10.1155/crh/8186265
Primary Topic
Blood properties and coagulation
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

“No End Point Detected”: A Unique Coagulation Profile Unmasking Dysfibrinogenemia

Xiu Yan Jiang, Kelsey Uminski
Case Reports in Hematology
Blood properties and coagulation
article

“No End Point Detected”: A Unique Coagulation Profile Unmasking Dysfibrinogenemia

Xiu Yan Jiang, Kelsey Uminski
article en

Abstract

Dysfibrinogenemia is a rare qualitative fibrinogen disorder that can present with bleeding, thrombosis, or both. We report a case of a young woman with first-trimester pregnancy loss and severe hemorrhage, whose coagulation tests reported "no end point detected" on PT, PTT, and Clauss fibrinogen assays. This pattern should prompt consideration of profound hypofibrinogenemia or qualitative fibrinogen defects. Fibrinogen replacement normalized PT and PTT and yielded measurable fibrinogen levels, enabling definitive diagnosis. Discordant activity and antigen levels, along with a pathogenic <i>FGB</i> variant, confirmed dysfibrinogenemia. This case underscores the importance of considering fibrinogen disorders in uninterpretable coagulation profiles and initiating early replacement.

Case Reports in HematologyVol. 2025(1)
University of Calgary (CA), Calgary Laboratory Services (CA)
CSL Behring, BioCryst, Novo Nordisk
Openalex Percentile: Top 71%
Blood properties and coagulation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.